🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at home.

After minutes of entering one group, a seller posted contact information, where most transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, posts display black plastic parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to possibly serious health risks”.